Nymox Pharmaceutical Corp (NYMX)
NASDAQ
Quarter End | 3 2022 | 6 2022 | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 9k | 0 | 0 | 0 | 0 | 0 |
営業利益 | -5.07M | -1.78M | -1.48M | 1.68M | -1.39M | -1.1M | -1.01M | -5.29M |
税引前収入 | -5.09M | 1.34M | -1.49M | -1.34M | -1.39M | -1.11M | -1.04M | -5.31M |
純利益 | -5.09M | 1.34M | -1.49M | -1.34M | -1.39M | -1.11M | -1.04M | -5.31M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -5.07M | 1.33M | -1.48M | -1.32M | -1.39M | -1.1M | -1.01M | -5.29M |
EBITDA | -5.07M | -1.78M | -1.48M | 1.69M | -1.38M | -987k | -973k | -5.45M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 283k | 224k | 299k | 116k | 5k | 0 | 0 | 0 |
営業利益 | -12.87M | -13.24M | -10.64M | -13.33M | -11.72M | -12.5M | -6.65M | -8.79M |
税引前収入 | -13.11M | -13.43M | -10.59M | -13.16M | -11.74M | -12.54M | -6.58M | -8.84M |
純利益 | -13.11M | -13.43M | -10.59M | -13.16M | -11.74M | -12.54M | -6.58M | -8.84M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.267 | -0.238 | -0.164 | -0.185 | -0.151 | -0.147 | -0.073 | -0.095 |
EBIT | -12.87M | -13.24M | -10.64M | -13.33M | -11.72M | -12.5M | -6.54M | -8.79M |
EBITDA | -12.87M | -13.23M | -10.64M | -13.33M | -11.71M | -12.49M | -6.64M | -8.79M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約